King Pharmaceuticals KG European Hospital Liability — Year 1
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's european hospital liability — year 1.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's european hospital liability — year 1?
- King Pharmaceuticals (KG) reported european hospital liability — year 1 of 3.2% in Q4 2025.
- What does european hospital liability — year 1 mean?
- This metric represents the development of claims or financial performance specifically for the first year of the underwriting cycle within the European Hospital Liability segment. It is used to analyze the initial loss emergence patterns and the accuracy of early-stage actuarial estimates for this product line.